Global Generic Injectables Market Report 2023: Aging Population and Rising Prevalence of Chronic Diseases Drives Growth
DUBLIN, May 25, 2023 /PRNewswire/ -- The "Generic Injectables Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.
The global generic injectable market is expected to grow at a CAGR of around 7.8% during 2023-2030.
- Hospira (Pfizer)
- Fresenius Kabi
- Hikma Pharma PLC
- Sandoz (Novartis)
- Sagent Inc.
- Dr. Reddy Laboratories
- Akorn Inc.
- Fresenius SE & Co. KGaA
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd
- Lupin Ltd
- Aurobindo Pharma
This report on global generic injectable market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.
The report presents a clear picture of the global generic injectable market by segmenting the market based on therapeutic area, containers, distribution channel, and region.
Also, detailed profiles of companies operating in the generic injectable market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
- Government Taking Initiatives to Support Manufacture in Various Countries
- Aging Population and Rising Prevalence of Chronic Diseases
- Cheaper and Shorter R&D
- Contamination Concerns for Injectable Manufactured in Factories in Some Countries
Historical & Forecast Period
- Base Year: 2022
- Historical Period: 2018-2022
- Forecast Period: 2023-2030
by Therapeutic Area
- Parenteral Nutrition
- Cardiovascular Diseases
- Prefilled Syringes
by Distribution Channel
- Retail Pharmacy
- United Kingdom
- Rest of Europe
- North America
- United States
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- Rest of Middle East & Africa
For more information about this report visit https://www.researchandmarkets.com/r/dn9v03
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/global-generic-injectables-market-report-2023-aging-population-and-rising-prevalence-of-chronic-diseases-drives-growth-301834955.html
SOURCE Research and Markets
Upcoming Life Sciences Events
- June 2023
- Boston: Product & Company Valuation Course
- BIO International Convention 2023
- RESI Boston
Latest company news
Multicancer Screening Global Market Report 2023: Sector to Reach $7.78 Billion by 2032 at a 15% CAGR
Haleon's Panadol Klinik Cekatan extends reach to people with limited mobility and healthcare access in areas affected by natural disasters
Lung Cancer Therapies Market to Amplify Significantly over 2022-2029 - Brandessence Market Research